http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1776333-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5ce2dd60671e5946f2e6db4891c3b32 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C237-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C215-90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-63 |
| filingDate | 2005-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ed45e074bd7e5a7a31e2dee5275d0f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_256c9c6d20fbdd5ad82b873277cfb928 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58ff989475a8f510df21efb7206922b5 |
| publicationDate | 2011-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1776333-B1 |
| titleOfInvention | Ammonium salts and ammonium salt/mineral salt clathrate compounds for use as vehicle and effective form for pharmaco-medical applications and for use as phase transfer agents for chemical applications |
| abstract | The invention relates to ammonium salts and stable storable ammonium salt/mineral salt clathrate compounds (inclusion compounds) having acidic dibasic acid residues such as hydrocarbonate, to methods for producing them and to pharmaco-medical and chemical synthetic applications for said compounds. According to the invention, compounds for pharmaco-medical and chemical synthetic applications are produced which comprise the ammonium salt and ammonium/mineral salt clathrate compounds (inclusion compounds, clusters) having acidic dibasic anionic acid residues of general formula (I) * x mole mineral salt, wherein R1, R2, R3 and R4 = alkyl and substituted alkyl straight-chain or branched, optionally having an alcohol, ether, silylether, ester, amino or amide function, H or aryl-alkyl, whereby aryl is an aromatic or heteroaromatic ring having optionally additional substituents, such as alkyl having 1 to 4 C atoms, OH, NR*2 with R*2= 0, alkyl with alkyl of from 1 to 4 C atoms or H, COOH, COOR, CN, NO2 and the cationic positive N+ optionally is part of an active agent, Y = a dibasic acid residue of an organic dicarboxylic acid or CO3, corresponding to HY- = HCO3-, and x = 0.5 to 30 represents the number of the mineral salt molecules for clathrate compound formation or 0. In pharmaco-medical applications, the ammonium salt/mineral salt cluster is used as vehicle and active agent for novel forms of application of nitrogen-containing active agent bases. In chemistry, these agents are used in the synthesis of active agents and valuable products, e.g. of cyclic carbonates. |
| priorityDate | 2004-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 210.